BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 29491627)

  • 1. Identification of Inhibitors against Metastasis Protein "
    Mishra S; Singh S
    Pharmacogn Mag; 2018 Jan; 13(Suppl 4):S742-S748. PubMed ID: 29491627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of novel PI3Kδ inhibitors by docking, ADMET prediction and molecular dynamics simulations.
    Liu YY; Feng XY; Jia WQ; Jing Z; Xu WR; Cheng XC
    Comput Biol Chem; 2019 Feb; 78():190-204. PubMed ID: 30557817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phytoconstituents from ten natural herbs as potent inhibitors of main protease enzyme of SARS-COV-2:
    Kumar N; Singh A; Gulati HK; Bhagat K; Kaur K; Kaur J; Dudhal S; Duggal A; Gulati P; Singh H; Singh JV; Bedi PMS
    Phytomed Plus; 2021 Nov; 1(4):100083. PubMed ID: 35403086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of the New Inhibitors by Sulfadiazine and Modified Derivatives of α-D-glucopyranoside for White Spot Syndrome Virus Disease of Shrimp by In Silico: Quantum Calculations, Molecular Docking, ADMET and Molecular Dynamics Study.
    Kumer A; Chakma U; Rana MM; Chandro A; Akash S; Elseehy MM; Albogami S; El-Shehawi AM
    Molecules; 2022 Jun; 27(12):. PubMed ID: 35744817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural insights into pharmacophore-assisted in silico identification of protein-protein interaction inhibitors for inhibition of human toll-like receptor 4 - myeloid differentiation factor-2 (hTLR4-MD-2) complex.
    Mishra V; Pathak C
    J Biomol Struct Dyn; 2019 May; 37(8):1968-1991. PubMed ID: 29842849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of anti-filarial leads against aspartate semialdehyde dehydrogenase of Wolbachia endosymbiont of Brugia malayi: combined molecular docking and molecular dynamics approaches.
    Amala M; Rajamanikandan S; Prabhu D; Surekha K; Jeyakanthan J
    J Biomol Struct Dyn; 2019 Feb; 37(2):394-410. PubMed ID: 29334340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacoinformatics exploration of polyphenol oxidases leading to novel inhibitors by virtual screening and molecular dynamic simulation study.
    Hassan M; Abbas Q; Ashraf Z; Moustafa AA; Seo SY
    Comput Biol Chem; 2017 Jun; 68():131-142. PubMed ID: 28340400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virtual screening, pharmacokinetics, molecular dynamics and binding free energy analysis for small natural molecules against cyclin-dependent kinase 5 for Alzheimer's disease.
    Shukla R; Singh TR
    J Biomol Struct Dyn; 2020 Jan; 38(1):248-262. PubMed ID: 30688165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational Simulations Identified Two Candidate Inhibitors of Cdk5/p25 to Abrogate Tau-associated Neurological Disorders.
    Zeb A; Son M; Yoon S; Kim JH; Park SJ; Lee KW
    Comput Struct Biotechnol J; 2019; 17():579-590. PubMed ID: 31073393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacophore-based virtual screening of catechol-o-methyltransferase (COMT) inhibitors to combat Alzheimer's disease.
    Patel CN; Georrge JJ; Modi KM; Narechania MB; Patel DP; Gonzalez FJ; Pandya HA
    J Biomol Struct Dyn; 2018 Nov; 36(15):3938-3957. PubMed ID: 29281938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A drug design strategy based on molecular docking and molecular dynamics simulations applied to development of inhibitor against triple-negative breast cancer by Scutellarein derivatives.
    Akash S; Aovi FI; Azad MAK; Kumer A; Chakma U; Islam MR; Mukerjee N; Rahman MM; Bayıl I; Rashid S; Sharma R
    PLoS One; 2023; 18(10):e0283271. PubMed ID: 37824496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of novel selective PI3Kγ inhibitors through combining machine learning-based virtual screening with multiple protein structures and bio-evaluation.
    Zhu J; Li K; Xu L; Cai Y; Chen Y; Zhao X; Li H; Huang G; Jin J
    J Adv Res; 2022 Feb; 36():1-13. PubMed ID: 35127160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combining empirical knowledge, in silico molecular docking and ADMET profiling to identify therapeutic phytochemicals from Brucea antidysentrica for acute myeloid leukemia.
    Bultum LE; Tolossa GB; Lee D
    PLoS One; 2022; 17(7):e0270050. PubMed ID: 35895695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Interaction and Computational Analytical Studies of Pinocembrin for its Antiangiogenic Potential Targeting VEGFR-2: A Persuader of Metastasis.
    Sharma N; Sharma M; Shakeel E; Jamal QMS; Kamal MA; Sayeed U; Khan MKA; Siddiqui MH; Arif JM; Akhtar S
    Med Chem; 2018; 14(6):626-640. PubMed ID: 29663896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Docking-based Screening of
    Chaudhary A; Yadav BS; Singh S; Maurya PK; Mishra A; Srivastva S; Varadwaj PK; Singh NK; Mani A
    Pharmacogn Mag; 2017 Oct; 13(Suppl 3):S706-S714. PubMed ID: 29142437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Target-based virtual screening, computational multiscoring docking and molecular dynamics simulation of small molecules as promising drug candidate affecting kinesin-like protein KIFC1.
    Khan MKA; Ahmad S; Rabbani G; Shahab U; Khan MS
    Cell Biochem Funct; 2022 Jul; 40(5):451-472. PubMed ID: 35758564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacoinformatics and molecular dynamics simulation-based phytochemical screening of neem plant (Azadiractha indica) against human cancer by targeting MCM7 protein.
    Ahammad F; Alam R; Mahmud R; Akhter S; Talukder EK; Tonmoy AM; Fahim S; Al-Ghamdi K; Samad A; Qadri I
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33834183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular docking analysis of aplysin analogs targeting survivin protein.
    Shakeel E; Akhtar S; Khan MKA; Lohani M; Arif JM; Siddiqui MH
    Bioinformation; 2017; 13(9):293-300. PubMed ID: 29081608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting Cytotoxin-Associated Antigen A, a Virulent Factor of
    He S; Almalki AA; Rafeeq MM; Sain ZM; Alqosaibi AI; Alnamshan MM; Al-Dhuayan IS; Rahaman A; Zhang Y; Banjer HJ; Anjum F; Alzghaibi HAM; Alharbi AH; Jamal QMS
    Molecules; 2022 Jan; 27(3):. PubMed ID: 35164000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-silico studies to recognize repurposing therapeutics toward arginase-I inhibitors as a potential onco-immunomodulators.
    Zaki MEA; Al-Hussain SA; Al-Mutairi AA; Samad A; Ghosh A; Chaudhari S; Khatale PN; Ajmire P; Jawarkar RD
    Front Pharmacol; 2023; 14():1129997. PubMed ID: 37144217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.